New eczema drug enters human testing: could it ease the itch?
Symptom relief
Recruiting now
This early-stage study is testing a new drug called BxC-I17e in 45 adults with moderate to severe eczema (atopic dermatitis). The main goal is to see if the drug is safe and tolerable when given as a shot under the skin. Participants will receive either the drug or a placebo, and…
Phase: PHASE1 • Sponsor: Brexogen Inc. • Aim: Symptom relief
Last updated May 26, 2026 12:02 UTC